GenFleet Therapeutics (Shanghai) Inc. Stock
Stocks
2595
CNE1000074L2
Biotechnology & Medical Research
|
Market Closed -
Hong Kong S.E.
04:08:28 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 27.40 HKD | -8.36% |
|
+5.79% | +15.22% |
| Market Cap | 8.69B 10.15B 1.29B 1.14B 1.08B 977M 1.83B 124B 1.84B 12.88B 4.97B 63.47B 4.86B 4.75B 204B | P/E 2026 * |
-19.2x | P/E 2027 * | -44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 7.22B 8.44B 1.08B 946M 895M 812M 1.52B 103B 1.53B 10.71B 4.13B 52.75B 4.04B 3.95B 169B | EV / Sales 2026 * |
62.8x | EV / Sales 2027 * | 25.4x |
| Free-Float |
73.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2595 | Delayed | |
Tradegate
| Y3L | Real-time | |
|
Boerse Muenchen
| Y3L | Real-time |
| 1 day | -8.36% | ||
| 1 week | +5.79% | ||
| Current month | -11.04% | ||
| 1 month | -15.22% | ||
| 3 months | +12.76% | ||
| 6 months | -16.00% | ||
| Current year | +15.22% |
| 1 week | 26.94 |  | 31.38 |
| 1 month | 23.74 | | 31.78 |
| Current year | 19.6 | | 52.9 |
| 1 year | 19.6 | | 52.9 |
| 3 years | 19.6 | | 52.9 |
| 5 years | 19.6 | | 52.9 |
| 10 years | 19.6 | | 52.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jiong Lan
CEO | Chief Executive Officer | 53 | 2017-08-21 |
Yu Wang
CTO | Chief Tech/Sci/R&D Officer | - | 2020-10-31 |
Wei Zhang
SEC | Corporate Secretary | 47 | 2026-03-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Jiong Lan
BRD | Director/Board Member | 53 | 2017-08-21 |
Qiang Lü
CHM | Chairman | 41 | 2017-08-21 |
Wei Zhang
BRD | Director/Board Member | 47 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.36% | +5.79% | -28.27% | - | 1.41B | |
| -0.37% | +1.12% | +57.21% | +84.56% | 72.26B | |
| -0.07% | -3.08% | +37.74% | +84.21% | 60.24B | |
| +0.75% | +6.06% | +36.71% | +19.87% | 27.73B | |
| -0.14% | -1.94% | -14.13% | +354.32% | 25.73B | |
| +0.57% | +3.14% | +1.02% | -3.92% | 24.75B | |
| +1.10% | +1.86% | +25.07% | -8.51% | 20.74B | |
| -1.70% | -2.12% | +150.24% | +323.16% | 15.06B | |
| +0.36% | +0.02% | +49.51% | +163.05% | 14.41B | |
| -2.53% | -1.39% | -6.38% | +469.36% | 14.23B | |
| Average | -1.04% | +1.42% | +30.87% | +165.12% | 27.66B | |
| Weighted average by Cap. | -0.16% | -0.96% | +37.80% | +125.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 115M 134M 17.13M 15.06M 14.25M 12.92M 24.28M 1.64B 24.41M 170M 65.79M 840M 64.3M 62.91M 2.7B | 284M 332M 42.3M 37.2M 35.19M 31.91M 59.95M 4.06B 60.27M 421M 162M 2.07B 159M 155M 6.66B |
| Net income | -453M -529M -67.45M -59.32M -56.11M -50.89M -95.6M -6.47B -96.1M -671M -259M -3.31B -253M -248M -10.62B | -198M -232M -29.58M -26.02M -24.61M -22.32M -41.93M -2.84B -42.15M -294M -114M -1.45B -111M -109M -4.66B |
| Net Debt | -1.47B -1.71B -218M -192M -182M -165M -310M -20.97B -311M -2.17B -839M -10.71B -820M -803M -34.39B | -1.47B -1.71B -218M -192M -182M -165M -310M -20.96B -311M -2.17B -839M -10.71B -820M -802M -34.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | HK$27.40 | -8.36% | 4,550,340 |
| 26-09-25 | HK$29.90 | -0.60% | 597,600 |
| 26-09-24 | HK$30.08 | -2.53% | 3,348,400 |
| 26-09-23 | HK$30.86 | +8.43% | 6,370,600 |
| 26-09-22 | HK$28.46 | -3.39% | 6,720,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2595 Stock
Select your edition
All financial news and data tailored to specific country editions
